After breathing new life into old mice, senescence startup Cleara bags cash to move toward the clinic

After breathing new life into old mice, senescence startup Cleara bags cash to move toward the clinic

Source: 
Fierce Biotech
snippet: 

Cleara Biotech has raised seed funding to advance a program that reversed aspects of aging in mice. The modified FOXO4-p53 interfering peptide program made headlines last year when it restored the physical fitness, hair growth and kidney function of mice.